Ali Jazayeri
Chief Technology Officer
HEPTARES
Switzerland
Biography
Ali joined Heptares in 2007 and as one of the first scientists he was involved in the transfer of the receptor stabilisation (StaR®) technology from MRC Laboratory of Molecular Biology to Heptares. Following successful implementation and industrialisation of the original technology, he led the development of novel methodologies that significantly increased the efficiency and reach of the StaR® technology. Prior to Heptares, Ali worked as a post-doctoral scientist in Clare Hall Laboratories (a Cancer Research UK institute) and Kudos Pharmaceuticals. In both cases he carried out research on the role of cell cycle checkpoint kinases in DNA damage response pathways. He has a BSc in Genetics from University of Manchester and obtained his PhD in molecular biology with Prof Steve Jackson at the Gurdon Institute from University of Cambridge.
Research Interest
molecular biology
